CN105301127B - 一种利巴韦林药物组合物及其有关物质检测方法 - Google Patents
一种利巴韦林药物组合物及其有关物质检测方法 Download PDFInfo
- Publication number
- CN105301127B CN105301127B CN201510656048.2A CN201510656048A CN105301127B CN 105301127 B CN105301127 B CN 105301127B CN 201510656048 A CN201510656048 A CN 201510656048A CN 105301127 B CN105301127 B CN 105301127B
- Authority
- CN
- China
- Prior art keywords
- ribavirin
- injection
- pharmaceutical composition
- related substance
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 title claims abstract description 70
- 229960000329 ribavirin Drugs 0.000 title claims abstract description 70
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 title claims abstract description 70
- 239000000126 substance Substances 0.000 title claims abstract description 30
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 13
- 238000002347 injection Methods 0.000 claims abstract description 42
- 239000007924 injection Substances 0.000 claims abstract description 42
- 239000007788 liquid Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 16
- 239000012071 phase Substances 0.000 claims description 13
- 238000001514 detection method Methods 0.000 claims description 8
- 239000012488 sample solution Substances 0.000 claims description 7
- 238000005259 measurement Methods 0.000 claims description 5
- 239000012074 organic phase Substances 0.000 claims description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 1
- 239000001488 sodium phosphate Substances 0.000 claims 1
- 239000012064 sodium phosphate buffer Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 8
- 239000000243 solution Substances 0.000 abstract description 8
- 238000002360 preparation method Methods 0.000 abstract description 6
- 239000000047 product Substances 0.000 abstract description 4
- 238000003908 quality control method Methods 0.000 abstract description 4
- 238000003756 stirring Methods 0.000 abstract description 4
- 239000008215 water for injection Substances 0.000 abstract description 4
- 238000001914 filtration Methods 0.000 abstract description 2
- 238000009472 formulation Methods 0.000 abstract description 2
- 239000013067 intermediate product Substances 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 238000011282 treatment Methods 0.000 abstract description 2
- 239000012535 impurity Substances 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 239000007791 liquid phase Substances 0.000 description 6
- 238000000691 measurement method Methods 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 6
- 239000012085 test solution Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000825 ultraviolet detection Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- RZMGZEJEAAVXRG-UHFFFAOYSA-N 1,2-dihydrotriazole-3-carboxylic acid Chemical compound N1NN(C=C1)C(=O)O RZMGZEJEAAVXRG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940017687 beta-d-ribose Drugs 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- HLGRRZFWTBVGMM-UHFFFAOYSA-L disodium;sulfate;dihydrate Chemical compound O.O.[Na+].[Na+].[O-]S([O-])(=O)=O HLGRRZFWTBVGMM-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510656048.2A CN105301127B (zh) | 2015-10-13 | 2015-10-13 | 一种利巴韦林药物组合物及其有关物质检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510656048.2A CN105301127B (zh) | 2015-10-13 | 2015-10-13 | 一种利巴韦林药物组合物及其有关物质检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105301127A CN105301127A (zh) | 2016-02-03 |
CN105301127B true CN105301127B (zh) | 2018-09-18 |
Family
ID=55198635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510656048.2A Active CN105301127B (zh) | 2015-10-13 | 2015-10-13 | 一种利巴韦林药物组合物及其有关物质检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105301127B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108434095A (zh) * | 2018-06-19 | 2018-08-24 | 吉林百年汉克制药有限公司 | 一种利巴韦林注射液药物组合物及其制备方法和应用 |
CN113030356B (zh) * | 2019-12-09 | 2022-09-27 | 武汉九州钰民医药科技有限公司 | 利巴韦林原料或制剂中有关物质的分离分析检测方法 |
CN110702677B (zh) * | 2019-12-16 | 2020-04-10 | 广州智汇生物科技有限公司 | 保健品中非法添加利巴韦林的检测方法 |
CN111812241B (zh) * | 2020-07-17 | 2023-02-14 | 广东华南药业集团有限公司 | 一种利巴韦林的分析方法及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102366401A (zh) * | 2011-09-28 | 2012-03-07 | 河南辅仁怀庆堂制药有限公司 | 利巴韦林注射液及其生产工艺 |
EP2690092A1 (en) * | 2009-06-18 | 2014-01-29 | Concert Pharmaceuticals Inc. | Deuterated isoindoline-1,3-dione derivatives as PDE4 and TNF-alpha inhibitors |
-
2015
- 2015-10-13 CN CN201510656048.2A patent/CN105301127B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2690092A1 (en) * | 2009-06-18 | 2014-01-29 | Concert Pharmaceuticals Inc. | Deuterated isoindoline-1,3-dione derivatives as PDE4 and TNF-alpha inhibitors |
CN102366401A (zh) * | 2011-09-28 | 2012-03-07 | 河南辅仁怀庆堂制药有限公司 | 利巴韦林注射液及其生产工艺 |
Non-Patent Citations (4)
Title |
---|
利巴韦林片有关物质测定方法的建立;张勤仓等;《药物与临床》;20090930;第47卷(第26期);第74-77页 * |
反相高效液相色谱法测定利巴韦林注射液的含量和有关物质;吴宏富等;《安徽医药》;20090131;第13卷(第1期);第1.2、2.2、2.4.4-3部分 * |
反相高效液相色谱法测定利巴韦林注射液的有关物质;吴宏富等;《药物鉴定》;20091231;第18卷(第7期);第17-18页 * |
对《中国药典》2010 年版利巴韦林注射液有关物质检查方法的探讨;王丽等;《药学与临床研究》;20141231;第22卷(第6期);第506-508页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105301127A (zh) | 2016-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105301127B (zh) | 一种利巴韦林药物组合物及其有关物质检测方法 | |
CN110907567B (zh) | 一种n-亚硝胺的提取分离检测方法 | |
CN108008026B (zh) | 一种山楂丸中13种着色剂同步检测的方法 | |
CN104777243B (zh) | 一种同时测定半夏中有机酸、核苷和麻黄碱的hplc方法 | |
CN107917972A (zh) | 一种高效液相色谱分析奥贝胆酸及其合成中间体的方法 | |
CN109839458A (zh) | 一种检测食品中匹可硫酸钠的方法 | |
CN109580806A (zh) | 一种用于水产品中利福平药物残留的测定方法 | |
CN105510457B (zh) | 一种检测牛奶中抗生素残留的方法 | |
CN103926332A (zh) | 一种同时测定半夏提取物中尿苷、鸟苷和腺苷含量的超高效液相色谱方法 | |
CN105353052B (zh) | 同时检测n-乙烯基吡咯烷酮和2-吡咯烷酮的方法 | |
CN108254471A (zh) | 低聚木糖中5-羟甲基糠醛和糠醛含量的检测方法 | |
CN113655135A (zh) | 一种马兜铃酸i的定量检测方法与限量方法 | |
CN105424834B (zh) | 同时检测聚维酮k30中2-吡咯烷酮和甲酸方法 | |
CN106706769B (zh) | 一种恩格列净及其光学异构体的分离测定方法 | |
CN106932522A (zh) | 一种尼罗替尼中杂质化合物i含量的测定方法 | |
CN105974000B (zh) | 7-苯甲酰基-1,3-二氢吲哚-2-酮在奈帕芬胺稳定性质量控制中的用途 | |
CN113376277B (zh) | 一种保健品中芬太尼类药物的高分辨质谱检测方法 | |
CN115598261A (zh) | 一种盐酸氯哌丁原料及其制剂中有关物质的测定方法 | |
CN104237399A (zh) | 测定安立生坦原料药及其制剂含量的方法 | |
CN104965031B (zh) | 复方酮洛芬奥美拉唑缓释胶囊的含量测定方法 | |
CN108872406A (zh) | 一种门冬氨酸原料药中有关物质的hplc分析检测方法 | |
CN110873767B (zh) | 一种右兰索拉唑合成中间体及其有关物质的快速检测方法 | |
CN110161152A (zh) | 一种盐酸青藤碱中杂质的检测方法 | |
CN112649525A (zh) | 小儿清热宣肺贴膏中栀子苷和苦杏仁苷的同时测定方法 | |
CN111337599A (zh) | 一种预处理方法、吗啡的检测方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a ribavirin pharmaceutical composition and a detection method of its related substances Effective date of registration: 20210730 Granted publication date: 20180918 Pledgee: Hunan Hanshou Rural Commercial Bank Co.,Ltd. Pledgor: KAMP PHARMACEUTICALS Co.,Ltd. Registration number: Y2021430000029 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211014 Granted publication date: 20180918 Pledgee: Hunan Hanshou Rural Commercial Bank Co.,Ltd. Pledgor: KAMP PHARMACEUTICALS Co.,Ltd. Registration number: Y2021430000029 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CP02 | Change in the address of a patent holder |
Address after: No.8 Kangpu Avenue, high tech Industrial Park, Hanshou County, Changde City, Hunan Province, 415900 Patentee after: KAMP PHARMACEUTICALS Co.,Ltd. Address before: 12 / F, building B, Lugu information port, 658 Lugu Avenue, high tech Zone, Changsha City, Hunan Province, 410205 Patentee before: KAMP PHARMACEUTICALS Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a ribavirin pharmaceutical composition and a detection method of its related substances Effective date of registration: 20211028 Granted publication date: 20180918 Pledgee: Hunan Hanshou Rural Commercial Bank Co.,Ltd. Pledgor: KAMP PHARMACEUTICALS Co.,Ltd. Registration number: Y2021980011259 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |